DataBreachSearch.com
All cases
investigating

Glenmark Pharmaceuticals Inc USA Reports Data Breach in Indiana

Glenmark Pharmaceuticals Inc USA has reported a data breach impacting personal information to Indiana authorities. The incident occurred on February 27, 2026, with the official filing made on March 17, 2026. Individuals who may be affected should review account statements and be alert to unusual activity to protect their data.

Compiled from official Attorney General recordsLast updated
State
IN
Breach date
February 27, 2026
Reported
March 17, 2026

Glenmark Pharmaceuticals Inc USA, a company operating in Indiana, recently filed a report confirming a data breach incident. This report was submitted to state officials on March 17, 2026, detailing an event that potentially exposed personal information.

The breach itself occurred on February 27, 2026. According to the public filing, the specific nature of the breach event that led to the exposure of data was not detailed in the available documentation.

The filing also does not specify the types of personal information involved in this incident, nor does it provide an exact number of individuals who may have been affected. Therefore, it is important for potentially impacted individuals to remain vigilant regarding any unusual activity.

At the time of the report, the status of the investigation into the breach by Glenmark Pharmaceuticals Inc USA was noted as ongoing. This indicates that further details may emerge as the company continues to assess the situation.

Individuals concerned about their data should take general protective measures. These include monitoring financial and personal accounts for suspicious transactions, being cautious of unsolicited communications, and considering changing passwords for critical online services. Reviewing credit reports regularly can also help identify unauthorized activity.

All information regarding this data breach involving Glenmark Pharmaceuticals Inc USA is derived from official public records submitted to state regulatory bodies, consistent with reporting requirements.

Source: Attorney General filing